Fluticasone furoate / Vilanterol bulk supplier for pharma manufacturers

Fluticasone Furoate / Vilanterol Suppliers & Bulk Manufacturers

Available Forms: Powder For Inhalation(DPI/MDI)

Available Strengths: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol

Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)

Category: Respiratory Disorder

Fluticasone furoate and vilanterol dry powder inhaler, 92/22 mcg and 184/22 mcg, a once-daily inhaled corticosteroid and LABA. For importers, distributors and hospital buyers supplying asthma and COPD maintenance therapy.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Fluticasone Furoate / Vilanterol? List it or send an offer →

Product Description:

This fixed-dose combination pairs fluticasone furoate, an inhaled corticosteroid that calms airway inflammation, with vilanterol, a long-acting beta2-agonist (LABA) that relaxes airway smooth muscle. Both act for a full day, so it is inhaled once daily. It is a breath-actuated dry powder inhaler, not a pressurised aerosol. Opening the cover prepares one dose from two foil blister strips, one per drug. Strengths are 92/22 mcg and 184/22 mcg, stated as delivered dose.

It is used for asthma maintenance, and the 92/22 mcg strength is also licensed for COPD, while 184/22 mcg is for asthma only. The dose is one inhalation once a day. It is not a reliever for sudden breathlessness. Rinsing the mouth after each dose limits oral thrush. Inhaled corticosteroids raise pneumonia rates in COPD. Strong CYP3A4 inhibitors such as ketoconazole or ritonavir increase exposure to both drugs, and non-selective beta-blockers can blunt the effect.

Sourcing notes. An inhaler is a drug-device combination, so ask for the device description, delivered dose uniformity and fine particle data with the CTD or ACTD dossier. Generic dry powder inhalers must show equivalence to the reference product through in vitro and often pharmacokinetic or clinical studies. Each inhaler is sealed in a foil tray with desiccant, and once opened its in-use life is limited, commonly to six weeks. Store below 25 °C; no cold chain. Request a batch CoA, the GMP certificate and a CoPP. It is prescription-only. State strength, doses per inhaler, market and label language in your enquiry.

Fluticasone Furoate / Vilanterol — third party manufacturing & bulk supply

Fluticasone Furoate / Vilanterol is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fluticasone Furoate / Vilanterol is supplied as Powder For Inhalation(DPI/MDI) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fluticasone Furoate / Vilanterol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fluticasone Furoate / Vilanterol →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Fluticasone furoate / vilanterol is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It helps reduce airway inflammation, improve lung function, and prevent symptoms such as wheezing, breathlessness, and exacerbations.

This combination is made from fluticasone furoate and vilanterol trifenatate. Fluticasone furoate is a corticosteroid that reduces inflammation in the airways, while vilanterol is a long-acting beta-2 agonist (LABA) that provides prolonged bronchodilation.

Common trade names include Breo Ellipta (USA), Relvar Ellipta (EU/UK), and various regional brands in global markets.

The original product is developed and marketed by GlaxoSmithKline (GSK) in collaboration with Innoviva. It is also manufactured by other pharmaceutical companies as per regional approvals.

The complete generic name is fluticasone furoate and vilanterol trifenatate.

Brand names include Breo Ellipta and Relvar Ellipta.

This inhalation product is manufactured globally in countries such as the USA, UK, EU nations, and other regions by innovator pharmaceutical companies and approved manufacturers.